U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2Al.3O4S
Molecular Weight 342.151
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALUMINUM SULFATE ANHYDROUS

SMILES

[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O

InChI

InChIKey=DIZPMCHEQGEION-UHFFFAOYSA-H
InChI=1S/2Al.3H2O4S/c;;3*1-5(2,3)4/h;;3*(H2,1,2,3,4)/q2*+3;;;/p-6

HIDE SMILES / InChI

Molecular Formula O4S
Molecular Weight 96.063
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Al
Molecular Weight 26.9815386
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.google.com/patents/US2824042 | https://www.ncbi.nlm.nih.gov/pubmed/22718290 | https://www.ncbi.nlm.nih.gov/pubmed/15516810 | https://www.ncbi.nlm.nih.gov/pubmed/10211213 | https://www.drugs.com/monograph/aluminum-acetate.html

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum sulfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

Originator

Curator's Comment: Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
DOMEBORO

Approved Use

Temporarily relieves minor skin irritations due to: – Poison ivy | – Poison oak – Poison sumac | – Insect bites – Athlete’s foot | – Rashes caused by soaps, detergents, cosmetics, or jewelry
Curative
DOMEBORO

Approved Use

This medication is used to treat an outer ear infection (external otitis). This product contains acetic acid/aluminum acetate, a combination that stops the growth of bacteria and fungus. Treating the infection reduces pain and swelling in the ear. Wetness in the ear canal can help bacteria and fungus to grow. This medication also causes drying of the ear canal, helping to cure the infection.
PubMed

PubMed

TitleDatePubMed
Molecular basis of carcinogenicity of tungsten alloy particles.
2015-03-15
1H NMR spectroscopic analysis detects metabolic disturbances in rat urine on acute exposure to heavy metal tungsten alloy based metals salt.
2014-03-25
Gene expression profile of mouse fibroblasts exposed to a biodegradable iron alloy for stents.
2013-11
Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine.
2007-10
Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
2007-10
Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet.
2007-09-18
Ototoxic effect of Burow solution applied to the guinea pig middle ear.
2007-08
Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
2006-11
Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration.
2006-11
Aluminum and Alzheimer's disease: a new look.
2006-11
The role of aluminum and copper on neuroinflammation and Alzheimer's disease.
2006-11
Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease.
2006-11
Some aspects of astroglial functions and aluminum implications for neurodegeneration.
2006-08-30
Aluminum and Alzheimer's disease, a personal perspective after 25 years.
2006
Aluminum: new recognition of an old problem.
2005-12
Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases.
2005-11
[Pharmaceutical and pharmacological evaluation of Burow's solution (aluminum acetate solution), hospital preparation, and development of its rapid preparation method].
2004-11
The role of metals in neurodegenerative processes: aluminum, manganese, and zinc.
2003-11-15
Aluminum inclusion macrophagic myofasciitis: a recently identified condition.
2003-11
Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain.
2003-09-15
Parenteral nutrition-associated cholestasis in neonates: the role of aluminum.
2003-09
Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite.
2003
Aluminum as a toxicant.
2002-08
Fluoride plus aluminum: useful tools in laboratory investigations, but messengers of false information.
2002
Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study.
1999-05
The antibacterial activity of acetic acid and Burow's solution as topical otological preparations.
1998-10
The ineffectiveness of aluminum subacetate in rheumatoid arthritis.
1948-04-08
Patents

Sample Use Guides

DOMEBORO® SOOTHING SOAK – dissolve 1 to 3 packets in a pint (16 oz) of cool or warm water – stir until fully dissolved; do not strain or filter. The resulting mixture contains 0.16% (1 packet), 0.32% (2 packets), or 0.48% (3 packets) aluminum acetate and is ready for use For use as a soak: – soak affected area for 15 to 30 minutes as needed, or as directed by a doctor – repeat 3 times a day or as directed by a doctor – discard solution after each use. For use as a compress or wet dressing: – soak a clean, soft cloth in the solution. – apply cloth loosely to affected area for 15 to 30 minutes – repeat as needed or as directed by a doctor – discard solution after each use
Route of Administration: Topical
Burow's solution (13% aluminum subacetate) is active against S. aureus and P. aeruginosa, resulting in damage to the cell wall.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:14:18 GMT 2025
Edited
by admin
on Mon Mar 31 18:14:18 GMT 2025
Record UNII
I7T908772F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALUMINUM SULFATE ANHYDROUS
HSDB   II  
Common Name English
E-520
Preferred Name English
NSC-54563
Code English
SULFURIC ACID ALUMINUM(3+) SALT (3:2)
Common Name English
ALUMINUM SULFATE ANHYDROUS [II]
Common Name English
ALUMINUM SULFATE ANHYDROUS [HSDB]
Common Name English
ALUMINUM SESQUISULFATE
Common Name English
ALUMINUM SULFATE [MI]
Common Name English
ALUMINUM SULPHATE ANHYDROUS
Common Name English
SULFATODIALUMINUM DISULFATE (AL2(SO4)3)
Systematic Name English
ALUMINII SULFAS, ANHYDROUS [WHO-IP LATIN]
Common Name English
INS-520
Code English
SULFURIC ACID, ALUMINUM SALT
Common Name English
DIALUMINUM TRISULFATE
Systematic Name English
SULFURIC ACID, ALUMINIUM SALT
Common Name English
Aluminium sulfate [WHO-DD]
Common Name English
DIALUMINUM SULFATE
Systematic Name English
INS NO.520
Code English
ALUMINIUM SULFATE ANHYDROUS
Common Name English
FERTOSAN
Common Name English
ALUMINIUM SULFATE, ANHYDROUS [WHO-IP]
Common Name English
ALUM CAKE
Common Name English
Classification Tree Code System Code
JECFA EVALUATION INS-520
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
CODEX ALIMENTARIUS (GSFA) INS-520
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
NCI_THESAURUS C2554
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
Code System Code Type Description
WHO INTERNATIONAL PHARMACOPEIA
ALUMINUM SULFATE ANHYDROUS
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY Description: Colourless, lustrous crystals or crystalline masses, or a white, crystalline powder; odourless. Solubility: Soluble in cold water; freely soluble in hot water; practically insoluble in ethanol (~750 g/l) TS. Category: Astringent drug; used in the preparation of aluminium acetate solution. Storage: Aluminium sulfate should be kept in a well-closed container.Aluminium sulfate contains a variable quantity of water of crystallization. Requirement: Aluminium sulfate contains not less than 51.0% and not more than the equivalent of 59.0% of Al2(SO4)3.
MERCK INDEX
m1630
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY Merck Index
FDA UNII
I7T908772F
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
NCI_THESAURUS
C228
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
PUBCHEM
24850
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID2040317
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
CHEBI
74768
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
HSDB
5067
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
CAS
10043-01-3
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
RXCUI
1593147
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY RxNorm
NSC
54563
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
DAILYMED
I7T908772F
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
ECHA (EC/EINECS)
233-135-0
Created by admin on Mon Mar 31 18:14:18 GMT 2025 , Edited by admin on Mon Mar 31 18:14:18 GMT 2025
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS
SOLVATE->ANHYDROUS
SALT/SOLVATE -> PARENT
SOLVATE->ANHYDROUS
Related Record Type Details
ACTIVE MOIETY
ACTIVE MOIETY